A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19
Clinical trial NCT04780685 · UNKNOWN
Trial details
- NCT number
- NCT04780685
- Sponsor
- Stemedica Cell Technologies, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-20
- Primary completion
- 2022-09-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.